ArticleFrontiers in endocrinology2025
Effects of short-term very low-calorie diet on metabolic profile in patients with metabolic syndrome.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accumulating evidence indicates that dietary modifications confer beneficial effects on metabolic syndrome (MetS). In clinical practice, short-term very low-calorie diets (VLCD) have been established as an effective intervention for improving MetS, even in the absence of exercise. However, the impact of a short-term VLCD on the serum metabolic profile of patients with MetS remains to be elucidated. Methods: 18 adult patients meeting the diagnostic criteria for MetS were enrolled and placed on a 9-day VLCD regimen. Anthropometric parameters, blood pressure, and lipid metabolism indices were measured before and after the intervention. Serum metabolic profiles were subsequently acquired using Results: Following the short-term VLCD intervention, patients with MetS exhibited significant reductions in body weight, waist circumference, and BMI ( Conclusions: Our study demonstrates that a short-term VLCD is an effective and safe intervention for improving anthropometric parameters, blood pressure, and lipid metabolism in patients with MetS. The observed therapeutic effects appear to be mediated through a remodeling of the serum metabolic profile and a concomitant modulation of key metabolic pathways. These findings provide a scientific rationale for the clinical application of short-term VLCD in MetS management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.